作者: Kent R. Thoelke , Alan R. Fritzberg , Mark D. Hylarides , Lauren Marie Tatalick , Paul G. Abrams
DOI:
关键词:
摘要: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near such as cancer, myeloproliferative diseases, autoimmune infectious metabolic diseases genetic with compositions having their active ingredient radionuclide complexed chelating agent macrocyclic aminophosphonic acid.